Keyphrases
Retinopathy
100%
Diabetic Macular Edema
82%
Diabetic Retinopathy
69%
Blood-retinal Barrier
57%
Blue Light
44%
Diabetic Patients
41%
Fluorescein
41%
IpRGC
38%
Retinal Thickness
37%
Visual Acuity
32%
Barrier Permeability
31%
Best-corrected Visual Acuity
29%
Type 2 Diabetes Mellitus (T2DM)
29%
Neovascular Age-related Macular Degeneration (nAMD)
28%
Macular Edema
28%
Diabetic
27%
Diabetic Retinopathy Screening
26%
Optical Coherence Tomography
26%
Diabetes
25%
Pupillometry
24%
Type 1 Diabetes Mellitus (T1DM)
24%
Melanopsin
24%
Red Light
24%
Active Transport
23%
Intravitreal Ranibizumab
21%
Clinically Significant Macular Edema
20%
Hemoglobin A1c (HbA1c)
20%
Healthy Controls
20%
Proliferative Diabetic Retinopathy
20%
Type I Diabetes
20%
Glaucoma
19%
Pupil Response
18%
Pupillary Response
18%
Ranibizumab
17%
Passive Transport
17%
Multifocal Electroretinogram (mfERG)
17%
Denmark
17%
Visual Outcome
16%
Pupillary Light Response
16%
Passive Permeability
16%
Light Stimulus
15%
Type 2 Diabetic Patients
15%
Pupillometrics
15%
Metabolic Control
15%
Pupillary Light Reflex
14%
Diabetes Duration
14%
Inter99
14%
Cataract Surgery
14%
Optos
13%
Glycemia
13%
Medicine and Dentistry
Diabetic Retinopathy
86%
Retinopathy
85%
Diabetes Mellitus
73%
Diabetic Macular Edema
62%
Diabetes
62%
Blood-Retinal Barrier
46%
Macular Edema
45%
Fluorescein
38%
Maturity Onset Diabetes of the Young
37%
Ganglion
37%
Pupillometry
37%
Visual Acuity
36%
Melanopsin
33%
Optical Coherence Tomography
33%
Insulin Dependent Diabetes Mellitus
23%
Laser Coagulation
22%
Cataract Surgery
19%
Active Transport
17%
Best Corrected Visual Acuity
16%
Prevalence
16%
Pupillary Response
16%
Patient with Type 2 Diabetes
15%
Fluorometry
14%
Vitreous
14%
Disease
14%
Photograph
13%
Ligation
12%
Ranibizumab
12%
Fundus Photography
12%
Passive Transport
12%
Vision
12%
Pupillary Reflex
12%
Vessel Diameter
11%
Edema
10%
Metabolic Regulation
10%
Autosomal Dominant Optic Atrophy
10%
Intraocular Lens
9%
Intravitreal Implant
9%
Vitrectomy
9%
Retinitis pigmentosa
9%
Prognostic Factor
9%
Dexamethasone
9%
Rett Syndrome
9%
Patient with Diabetes
9%
Proliferative Diabetic Retinopathy
9%
Eye Disease
9%
Hemoglobin A1c
9%
Mydriatic Agent
9%
Hyperglycemia
8%
Visual Impairment
8%